Work

Combination ruxolitinib, belumosudil, and axatilimab yields clinically significant symptomatic improvements in treatment-refractory chronic GVHD

Year: 2025

Type: article

Source: Bone Marrow Transplantation

DOI: 10.1038/s41409-025-02764-2

Authors: Jean Caputo, Ayush Peddireddi, Sarah Wall, Sumithira Vasu, Sam L. Penza, Kevin Ho, Vincent Esguerra, Benjamin H. Kaffenberger, Hannah K. Choe

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, The Ohio State University Wexner Medical Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416359338

FWCI: 0.737

Cites: 11

Cited by: 1

Related to: 10